Susquehanna International Group Ltd. Novo Nordisk A S Transaction History

Susquehanna International Group Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$102.11 - $135.92 $459,699 - $611,911	4,502 New	4,502 $578,000
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $1.25 Million - $2.75 Million	13,781 Added 112.53%	26,027 $2.37 Million
Q2 2023 Aug 11, 2023	BUY	$155.98 - $172.65 $1.91 Million - $2.11 Million	12,246 New	12,246 $1.98 Million
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $1.58 Million - $1.77 Million	-33,766 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $1.4 Million - $1.6 Million	33,766 New	33,766 $1.56 Million

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $246B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Susquehanna International Group Ltd., based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group Ltd. with notifications on news.